Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Discover whether stocks or bonds are better for achieving financial freedom. Start making smarter investment decisions today.
26,067 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
With inflation stubborn and growth resilient, traders are debating whether the Fed will hold rates in June or pivot l...
Gordon Ritter argues that AI’s learning loop isn’t a job-killer countdown, but a shift toward human-driven innovation...
A widowed 85-year-old is at the center of a rapid debate over lending to seniors as major banks pursue high-rate cred...
84-year-old Senator Mitch McConnell was hospitalized over the weekend with details undisclosed. With his term ending ...
A Michigan case alleges a dentist billed Medicaid for work not performed. This article explains what happened, how Me...
PwC’s new AI Jobs Barometer reveals a pivotal shift in hiring: entry-level work didn’t disappear, it evolved into sen...
Tether earns money mainly from interest on the reserves backing USDT. As market yields rise and policy moves shift, t...
A message that seems to come from the boss can trigger a chain of costly actions. This guide breaks down how these sc...
Glenn Kelman has joined Greylock Partners as an executive in residence, months after stepping down from Redfin and fo...
As AI builds out more data centers, the U.S. power grid faces mounting strain. HPE’s warning of a looming 19 gigawatt...
Google’s looming compute constraint and a $462 billion backlog set the stage for a broader AI access debate. Investor...